$3.31
-0.22-6.23%
At close: Jan 23, 4:00 PM EST
$3.51
0.206.04%
After Hours: 9:27 AM EST
Comments
Loading...
Galectin Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:GALT | Benzinga
Galectin Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 30
EPS Estimate
$-0.100
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Galectin Therapeutics using advanced sorting and filters.
Galectin Therapeutics (GALT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-14 | $-0.13 | $-0.11 | -18.2 % |
| Q2 | 2025-08-14 | $-0.12 | $-0.16 | 25.0 % |
| Q4 | 2025-03-31 | $-0.19 | $-0.21 | 9.52 % |
| Q3 | 2024-11-13 | $-0.18 | $-0.20 | 10.0 % |
Galectin Therapeutics (GALT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Galectin Therapeutics (NASDAQ:GALT) reporting earnings?
Galectin Therapeutics (GALT) is scheduled to report earnings on March 30, 2026. The last reported earnings were for reported on November 14, 2025 for Q3.
What were the latest earnings per share (EPS) for Galectin Therapeutics (NASDAQ:GALT)?
The Actual EPS was $-0.13, which missed the estimate of $-0.11.
What were Galectin Therapeutics’s (NASDAQ:GALT) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
